Mid Atlantic Retina — Philadelphia, Pennsylvania

Mid Atlantic Retina is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Mid Atlantic Retina has participated in 36 clinical trials with 9 currently active.

Therapeutic areas: Geographic Atrophy, Diabetic Macular Edema, Dry Age-related Macular Degeneration.

Sponsors: Hoffmann-La Roche, Complement Therapeutics, Santen Inc..

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid Atlantic Retina?

Mid Atlantic Retina has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid Atlantic Retina conducted?

Mid Atlantic Retina has 36 clinical trials on record, with 9 currently active. Their work covers Geographic Atrophy, Diabetic Macular Edema, Dry Age-related Macular Degeneration.

Is Mid Atlantic Retina accredited by Crixeo Health?

Mid Atlantic Retina has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid Atlantic Retina?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.